Correlation of serum magnesium levels with severity of liver disease in cirrhosis patients
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251647Keywords:
Cirrhosis liver, Hypomagnesaemia, CTP score, MELD, MicronutrientsAbstract
Background: Chronic liver disease (CLD) patients are prone to micronutrient disturbances particularly magnesium secondary to malnutrition and disturbed hepatic metabolism which may further exacerbate liver dysfunction. The child-turcotte-pugh (CTP) score and the model for end-stage liver disease (MELD) are established indices for cirrhosis prognostication. The ail of the study was to estimate serum magnesium levels in patients with chronic liver disease and to examine the correlation between serum magnesium levels and the severity of liver disease, as assessed by the MELD and child-pugh scores.
Methods: This cross-sectional observational study recruited 121 participants meeting the inclusion criteria over a period of six months. Informed consent was obtained. Basic investigations were done, including complete blood count, renal and liver function tests, PT-INR, and serum magnesium levels. MELD and child-pugh scores were calculated, and data analysis was performed using SPSS software.
Results: The median age of the participants was 45 years, with 85.12% being male and the predominant etiology being alcohol-related liver disease. The prevalence of Hypomagnesemia was 58.33%. A statistically significant correlation was observed between lower magnesium levels and higher child-pugh class, particularly in class C patients. There was a significant negative correlation between magnesium levels and MELD scores.
Conclusions: The findings underscore the need for further randomised controlled trials to evaluate the efficacy of magnesium supplementation in slowing disease progression and preventing cirrhosis complications. This potential treatment could significantly reduce morbidity and mortality, offering a promising outlook for the future of cirrhosis management.
Metrics
References
Peng X, Xiang R, Li X, Tian H, Li C, Peng Z, et al. Magnesium deficiency in liver cirrhosis: a retrospective study. Scandinavian journal of gastroenterology. 2021;56(4):463-8. DOI: https://doi.org/10.1080/00365521.2021.1888154
Llibre-Nieto G, Lira A, Vergara M, Solé C, Casas M, Puig-Diví V, et al. Micronutrient deficiencies in patients with decompensated liver cirrhosis. Nutrients. 2021;13(4):1249. DOI: https://doi.org/10.3390/nu13041249
Liu M, Yang H, Mao Y. Magnesium and liver disease. Ann Transl Med. 2019;7(20):578. DOI: https://doi.org/10.21037/atm.2019.09.70
Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42 Suppl(1):S100-7. DOI: https://doi.org/10.1016/j.jhep.2004.11.015
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646-9. DOI: https://doi.org/10.1002/bjs.1800600817
Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-70. DOI: https://doi.org/10.1053/jhep.2001.22172
Wu L, Zhu X, Fan L, Kabagambe EK, Song Y, Tao M, et al. Magnesium intake and mortality due to liver diseases: Results from the Third National Health and Nutrition Examination Survey Cohort. Sci Rep. 2017;7(1):17913. DOI: https://doi.org/10.1038/s41598-017-18076-5
Chavan M, Nadagoudar SB, Boke U. Study of serum magnesium in liver disease - a cross-sectional observational study conducted in Bagalkot District, Karnataka. J Evid Based Med Healthc. 2021;8(42):3646.
Veena G, James R. Prevalence of hypomagnesemia in cirrhosis of liver and its association with severity of the disease. Asian J Pharm Clin Res. 2022;15(8):92-5. DOI: https://doi.org/10.22159/ajpcr.2022.v15i8.45029
Rani P, Goel R, Madaan H. Assessment of serum magnesium levels in patients with liver cirrhosis and its correlation with severity of disease. Int J Acad Med Pharm. 2024;6(3):462-6.
Das B, Chandra P, Thimmaraju KV. Serum magnesium level in patients with liver cirrhosis. Int J Biol Med Res. 2011;2(3):709-11.
Gowda P, Tembad M. Study of serum magnesium in liver diseases. J Evol Med Dent Sci. 2015;4:3047-56. DOI: https://doi.org/10.14260/jemds/2015/443
Koivisto M, Valta P, Höckerstedt K, Lindgren L. Magnesium depletion in chronic terminal liver cirrhosis. Clin Transplant. 2002;16(5):325-8. DOI: https://doi.org/10.1034/j.1399-0012.2002.01141.x
Kar K, Dasgupta A, Vijaya Bhaskar M, Sudhakar K. Alteration of micronutrient status in compensated and decompensated liver cirrhosis. Indian J Clin Biochem. 2014;29(2):232-7. DOI: https://doi.org/10.1007/s12291-013-0349-5
Nangliya V, Sharma A, Yadav D, Sunder S, Nijhawan S, Mishra S. Study of trace elements in liver cirrhosis patients and their role in prognosis of disease. Biol Trace Elem Res. 2015;165(1):35-40. DOI: https://doi.org/10.1007/s12011-015-0237-3
Poikolainen K, Alho H. Magnesium treatment in alcoholics: a randomized clinical trial. Subst Abuse Treat Prev Policy. 2008;3:1. DOI: https://doi.org/10.1186/1747-597X-3-1
Gullestad L, Dolva LØ, Birkeland K, Falch D, Fagertun H, Kjekshus J. Oral versus intravenous magnesium supplementation in patients with magnesium deficiency. Magnes Trace Elem. 1991;10(1):11-6.
Eshraghian A, Nikeghbalian S, Geramizadeh B, Malek-Hosseini SA. Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis. United Eur Gastroenterol J. 2017;6(1):97-103. DOI: https://doi.org/10.1177/2050640617707863
Dumea M, Cimpoesu DC, Nechifor M. Divalent cations profile in patients with liver cirrhosis and variceal bleeding. Rev Med Chir Soc Med Nat Iasi. 2015;119(4):1166-73.
Rahelić D, Kujundzić M, Romić Z, Brkić K, Petrovecki M. Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis. Coll Antropol. 2006;30(3):523-8.
Downloads
Published
How to Cite
Issue
Section
